Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03688100 · ClinicalTrials.gov registry record · Phase 4
Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 494
- Enrollment target
NCT03688100 is a Phase 4 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 494 participants.
The verdict
NCT03688100, a Phase 4 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 494 participants
- Enrollment target
Study Summary
We are doing this study to help patients, caregivers, and providers make decisions about how best to manage depressive symptoms in advanced heart failure. There are two evidence-based treatment approaches to treating depression in patients with advanced heart failure, behavioral action psychotherapy and treatment with anti-depressant medications. In this study we want to compare the effectiveness of these two treatment options to learn which treatment works better.
Interventions
- BEHAVIORAL Behavioral Activation Therapy
- DRUG Medication Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2022-05-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03688100
The ClinicalTrials.gov registry entry for NCT03688100 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral Activation Therapy is the first listed.
NCT03688100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03688100 about?
NCT03688100 is a clinical study titled "Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure". We are doing this study to help patients, caregivers, and providers make decisions about how best to manage depressive symptoms in advanced heart failure. There are two evidence-based treatment approaches to treating depression in patients with advanced heart failure, behavioral action psychotherapy...
What is the current status of trial NCT03688100?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 494 participants. The study started on 2018-11-09. Estimated completion is 2022-05-06.
What interventions are being tested in trial NCT03688100?
The interventions under investigation include: Behavioral Activation Therapy (BEHAVIORAL), Medication Management (DRUG).
Who is sponsoring clinical trial NCT03688100?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.